Medical Developments International Limited
MDDVF
$0.3206
-$0.187-36.84%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 6.11M | 5.98M | 6.51M | 6.70M | 5.95M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.11M | 5.98M | 6.51M | 6.70M | 5.95M |
| Cost of Revenue | 1.40M | 1.37M | 1.72M | 1.76M | 1.55M |
| Gross Profit | 4.71M | 4.61M | 4.80M | 4.93M | 4.40M |
| SG&A Expenses | 4.50M | 4.41M | 3.92M | 4.03M | 4.57M |
| Depreciation & Amortization | 514.40K | 503.70K | 520.30K | 535.00K | 615.50K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.42M | 6.28M | 6.15M | 6.33M | 6.73M |
| Operating Income | -307.80K | -301.40K | 359.10K | 369.20K | -778.30K |
| Income Before Tax | -47.70K | -46.70K | 103.30K | 106.20K | -6.64M |
| Income Tax Expenses | 19.50K | 19.10K | 4.20K | 4.40K | 3.26M |
| Earnings from Continuing Operations | -67.30K | -65.90K | 99.00K | 101.80K | -9.90M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -67.30K | -65.90K | 99.00K | 101.80K | -9.90M |
| EBIT | -307.80K | -301.40K | 359.10K | 369.20K | -778.30K |
| EBITDA | -62.30K | 25.80K | 879.40K | 904.20K | -724.20K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | -0.11 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | -0.11 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| Average Basic Shares Outstanding | 112.61M | 112.61M | 107.37M | 107.37M | 86.31M |
| Average Diluted Shares Outstanding | 112.61M | 112.61M | 112.58M | 112.58M | 86.31M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |